CNOBP vs CPAY: which is the better buy in 2026?
On Alexandria's Compass, ConnectOne Bancorp, Inc. - Depo has the edge with a 94/100 score versus 91/100 for CPAY. Here is how they stack up, factor by factor.
ConnectOne Bancorp, Inc. - Depo
NASDAQ:CNOBP
A depositary preferred trading at par with a 5.25% coupon, this is income, not a growth story dressed up as one.
Full CNOBP analysisCorpay, Inc.
NYSE:CPAY
B2B payments compounder trading at 11.5x forward earnings while growing 25% and printing $2.1B free cash, the market still treats it like a gas card company.
Full CPAY analysisFactor by factor
Get head-to-heads like this, free
Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is CNOBP or CPAY the better buy in 2026?
By Compass Score, ConnectOne Bancorp, Inc. - Depo (NASDAQ:CNOBP) edges it at 94/100 versus 91/100 for CPAY. Both scores update weekly and reflect a contrarian, forward-looking read, not a recommendation.
How does Alexandria compare CNOBP and CPAY?
Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.
Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.